March 2024

NDRI expands postgraduate student research

NDRI has expanded into new areas of research and strengthened its Justice Health program with new postgraduate scholars beginning their doctorate and masters studies in recent months.

Read more
July 2022

Register now for the 2022 NDARC Annual Research Symposium

Registration is open for the 2022 symposium, which will showcase the work of leading AOD national and international researchers.

July 2022

An Outcomes Framework for information and support services

The Framework provides a uniform vision for what service quality and success can look like and suggested metrics for quality and success.

July 2022

NDARC Early Career Networking Event

Registration is now open for the 2022 NDARC Annual Research Symposium.

July 2022

NDRI marks NAIDOC week

NDRI’s Aboriginal Research Team hosted a special event to mark NAIDOC Week, sharing and highlighting the 2022 ‘Get Up! Stand Up! Show Up!’ theme.

July 2022

Can tailored text message support programs help close the gap in treatment outcomes experienced by smokers from low socioeconomic backgrounds?

NDARC’s Dr. Ryan Courtney and his team highlight the importance of quit smoking research in low socioeconomic populations.

July 2022

Register now for NDARC webinars in July and August

Registration is now open for NDARC webinars in July and August.

July 2022

New report finds five drug-induced deaths per day among Australians in 2020

There were 1,842 drug-induced deaths among Australians in 2020, according to preliminary estimates in a new report by the Drug Trends program at NDARC.

July 2022

Rural and regional NSW focus of alcohol and other drug prevention funding

NDARC researchers have been awarded $1.7 million over four years for a program of work focused on the prevention of AOD use and harms in rural and regional NSW.

July 2022

World-first trial to compare vaporised nicotine products and varenicline for smoking cessation

NDARC’s Ryan Courtney has been awarded $2.7 million to compare the cost-effectiveness of vaporised nicotine products (VNPs) and varenicline.

July 2022

Impact of OAT on hospitalisations – NDRI webinar series

NDRI Melbourne’s Samantha College-Frisby presented NDRI’s July webinar, sharing findings from studies examining the impact of opioid agonist treatment (OAT) on ho

Pages